Brenntag AG (FRA:BNR) Receives €52.33 Consensus Target Price from Analysts

Share on StockTwits

Shares of Brenntag AG (FRA:BNR) have been assigned an average recommendation of “Buy” from the sixteen brokerages that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is €52.33 ($60.85).

Several research analysts recently commented on BNR shares. Baader Bank set a €50.00 ($58.14) price objective on shares of Brenntag and gave the stock a “buy” rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. set a €50.00 ($58.14) price objective on shares of Brenntag and gave the stock a “buy” rating in a research note on Wednesday. Deutsche Bank set a €52.00 ($60.47) price objective on shares of Brenntag and gave the stock a “buy” rating in a research note on Thursday, August 8th. Independent Research set a €46.00 ($53.49) price objective on shares of Brenntag and gave the stock a “neutral” rating in a research note on Friday, August 9th. Finally, UBS Group set a €52.50 ($61.05) price objective on shares of Brenntag and gave the stock a “buy” rating in a research note on Monday, August 5th.

FRA BNR opened at €41.69 ($48.48) on Friday. The company has a 50 day moving average price of €43.04 and a 200 day moving average price of €44.46. Brenntag has a 52 week low of €43.06 ($50.07) and a 52 week high of €56.25 ($65.41).

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Recommended Story: Diluted Earnings Per Share

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Reata Pharmaceuticals Inc to Post FY2019 Earnings of  Per Share, Cantor Fitzgerald Forecasts
Reata Pharmaceuticals Inc to Post FY2019 Earnings of Per Share, Cantor Fitzgerald Forecasts
CGI Inc  Holdings Decreased by Financial Gravity Wealth Inc.
CGI Inc Holdings Decreased by Financial Gravity Wealth Inc.
Brokers Offer Predictions for Astronics Co.’s Q3 2019 Earnings
Brokers Offer Predictions for Astronics Co.’s Q3 2019 Earnings
FY2019 EPS Estimates for Timkensteel Corp Cut by G.Research
FY2019 EPS Estimates for Timkensteel Corp Cut by G.Research
Capital Investment Services of America Inc. Sells 3,425 Shares of Microsoft Co.
Capital Investment Services of America Inc. Sells 3,425 Shares of Microsoft Co.
Pacer Advisors Inc. Grows Stock Holdings in Hologic, Inc.
Pacer Advisors Inc. Grows Stock Holdings in Hologic, Inc.


© 2006-2019 Ticker Report